Table 1.
Fig. 3 panel |
Sample source | Antibody used for immuno-gold labeling |
Refs. |
---|---|---|---|
Evidence for OUTER mitochondrial membrane labeling | |||
A | BAX transfected Cos-7 cells | Anti-Bax | [91] |
B | SU-DHL-4 cells | Anti-Bcl-2 monoclonal MAb #100 | Fig. 4 of [92] |
C | Human lymph node biopsy/ lymphoma | Monoclonal mouse anti-human Bcl-2 (Dako 124) | Fig. 1D of [93] |
D | Human lymph node biopsy/ lymphoma | Monoclonal mouse anti-human Bcl-2 (Dako 124) | Fig. 1E of [93] |
E | Human lymph node biopsy/ lymphoma | Monoclonal mouse anti-human Bcl-2 (Dako 124) | Fig. 1C of [93] |
F | FDC-P1 myeloid cells +bcl-2/neo virus | Monoclonal antibody Bcl-2–100 | Fig. 3A of [94] |
Evidence for INNER mitochondrial membrane labeling | |||
G | HL60 (human promyelocytic leukemia) | Anti-BCL-2 “pAb” (rabbit anti-human BCL-2 polyclonal against amino acids 4–21 of human/mouse/rat on 10 nm gold) | Fig. 2B of [84] |
H | Mouse brain (hippocampus) | Rabbit anti-BCL-xL (Biocarta) | [33] |
I | HeLa (human epithelial cancer) stably expressing human BCL-2 | Anti-BCL-2ΔC21 “mAb” (Santa Cruz) where 60% of mitochondrial label is inside mitochondria | [86] |
J | HL60 | Anti-BCL-2 “pAb” (10 nm gold) co-labeled with anti-monoamine oxidase (20 nm gold, black arrows) to mark outer mitochondrial membrane | Fig. 3A of [84] |
K | Rat liver | Rabbit anti-human BCL-2 polyclonal antibody “pAb” (10 nm gold), which is enriched in mitochondria rather than ER | Fig. 2A of [84] |
L | Rat brain | Rabbit anti-BCL-xL (Biocarta, 10 nm gold, 5 nm gold, white arrows), co-labeled with and with anti-SOD (5 nm gold) | [34] |
M | Isolated PC12 mitochondria | Anti-Bcl-2 [anti-rat Bcl-2, PharMingen], cryothin-section immunogold | Fig. 4B of [85] |
N | Mouse brain (hippocampus) | Rabbit anti-BCL-xL (Biocarta) | [33] |
O | bcl-x conditional knockout mouse brain (hippocampus) | Rabbit anti-BCL-xL (Biocarta) prepared in parallel with panels H and N | [33] |